  See all
 |
Articles: Pharmacology/Therapy |
Prior Articles
Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine
Medical Oncology, 10/23/09
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer
Journal of Clinical Oncology, 10/22/09
Exclusive Author Commentary Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
BMC Cancer, 10/22/09
Free full text
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma
New England Journal of Medicine, 10/22/09 Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry.
Annals of Rheumatic Diseases, 10/22/09 Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/22/09 Novel agents for the treatment of adenocarcinoma of the pancreas
Expert Review of Anticancer Therapy, 10/22/09
Revew Article
Radiochemotherapy in the elderly with lung cancer
Expert Review of Anticancer Therapy, 10/22/09 Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer
Cancer, 10/22/09 Bosutinib: a dual SRC/ABL kinase inhibitor for the treatment of chronic myeloid leukemia
Expert Review of Hematology, 10/22/09 Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy
Expert Review of Anticancer Therapy, 10/22/09 Clinical activity of laromustine (Onrigin) in hematologic malignancies
Expert Review of Hematology, 10/22/09 Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue
Expert Review of Anticancer Therapy, 10/22/09 Efficacious but insidious: A retrospective analysis of fludarabine-induced myelotoxicity using long-term culture?initiating cells in 100 follicular lymphoma patients
Experimental Hematology, 10/22/09 The prognostic significance of single hormone receptor positive metastatic breast cancer: An analysis of three randomised phase III trials of aromatase inhibitors
The Breast, 10/21/09 Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
Cancer Chemotherapy and Pharmacology, 10/21/09 Palliative Oncology: Thalidomide
American Journal of Hospice and Palliative Medicine, 10/21/09 Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer
Expert Review of Anticancer Therapy, 10/21/09 Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial
Expert Review of Anticancer Therapy, 10/21/09 Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
Cancer Research, 10/21/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
